Trials / Sponsors / Werewolf Therapeutics, Inc.
Werewolf Therapeutics, Inc.
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | A Phase 1b/2 Multisite Dose-finding and Expansion Study of WTX-330 in Adult Patients With Selected Advanced or Advanced or Metastatic Solid Tumors, Non-Hodgkin Lymphoma | Phase 1 / Phase 2 | 2025-05-07 |
| Completed | WTX-330 in Patients With Advanced or Metastatic Solid Tumors or Non-Hodgkin Lymphoma Advanced or Metastatic Solid Tumors, Non-Hodgkin Lymphoma | Phase 1 | 2022-12-06 |
| Active Not Recruiting | Dose Escalation and Expansion Study of WTX-124 as Monotherapy and in Combination With Pembrolizumab (Pembro) i Metastatic Solid Tumor, Advanced Solid Tumor | Phase 1 | 2022-05-20 |